ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University
[Activation of the CaMKKβ/AMPK/HIF-1α signaling pathway promotes angiogenesis in endometriosis by regulating mitophagy].
Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo investigate whether the CaMKKβ/AMPK/HIF-1α signaling pathway participates in angiogenesis in endometriosis by regulating mitophagy.
methodsHuman endometrial stromal cells (hEM15A) isolated from endometriosis patients and normal endometrial stromal cells (HESCs) from non-endometriosis women were tested for proliferation, invasion, migration and tube formation abilities using CCK-8 assay, scratch assay and in vitro angiogenesis test. The protein and mRNA expression levels of CaMKKβ, AMPK, HIF-1α, BNIP3, LC3, VEGF and CD31 in the cells were detected by Western blotting and qPCR. MitoTracker Green, MitoSOX Red fluorescent probes and immunofluorescence staining were used to observe mitochondrial morphology, mtROS level and BNIP3/LC3 co-localization. CaMKKβ agonists and inhibitors were used to verify the function of the CaMKKβ/AMPK/HIF-1α pathway.
resultsCompared with HESCs, hEM15A cells showed stronger proliferation, invasion, migration and angiogenesis abilities with significantly up-regulated expressions of CaMKKβ, AMPK, HIF-1α, BNIP3, LC3, VEGF and CD31. hEM15A cells showed increased number of mitochondria with intact structure, but the localization signals of BNIP3 and LC3 and mtROS level increased significantly. Mechanistically, inhibition of CaMKKβ significantly reduced expressions of AMPK, BNIP3, LC3, HIF-1α, VEGF and CD31, while activation of CaMKKβ increased expressions these proteins, down-regulated mitochondrial autophagy and inhibited angiogenesis.
conclusionsCaMKKβ/AMPK is abnormally activated in endometriosis to result in excessive accumulation of HIF-1α, which in turn increases the expression of its downstream target gene BNIP3, thus promoting mitophagy to trigger abnormal angiogenesis, which can be inhibited by inhibiting abnormal activation of CaMKKβ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.